Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (331-340 of 524) with videos related to

Pageof 53
Sort By:
Journal of Diabetes and Its Complications|June 18, 2024
Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?Djordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis, et al.
Archives of Medical Science : AMS|August 2, 2021
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemiaMaciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Current Pharmaceutical Design|April 7, 2025
Steatotic Shadows: The Dark Link Between Metabolic Dysfunction-associated Steatotic Liver Disease and Cancer RiskShakta Mani Satyam, Mohamed El-Tanani, Syed Arman Rabbani, et al.
Biomedicines|November 27, 2024
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?Paschalis Karakasis, Marios Sagris, Dimitrios Patoulias, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 21, 2018
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanismsManfredi Rizzo, Dragana Nikolic, Angelo Maria Patti, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Incretin-Based Therapies and Cancer: What's New?Sanja Medenica, Jelena Bogdanovic, Jelena Vekic, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging StrategiesSyed Arman Rabbani, Manita Saini, Mohamed El-Tanani, et al.
Current Pharmaceutical Design|March 21, 2017
Nutraceuticals as an Important Part of Combination Therapy in DyslipidaemiaAngelo M Patti, Peter P Toth, Rosaria V Giglio, et al.
Molecular Medicine Reports|August 31, 2016
Plasma heme oxygenase-1 is decreased in peripheral artery disease patientsSalvatore Santo Signorelli, Guido Li Volsi, Valerio Fiore, et al.
Metabolites|November 10, 2022
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular PreventionAmalia Despoina Koutsogianni, Petros Spyridonas Adamidis, Fotios Barkas, et al.
Pageof 53

Showing results (331-340 of 524) with videos related to

Sort By:
Pageof 53
Journal of Diabetes and Its Complications|June 18, 2024
Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?Djordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis, et al.
Archives of Medical Science : AMS|August 2, 2021
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemiaMaciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Current Pharmaceutical Design|April 7, 2025
Steatotic Shadows: The Dark Link Between Metabolic Dysfunction-associated Steatotic Liver Disease and Cancer RiskShakta Mani Satyam, Mohamed El-Tanani, Syed Arman Rabbani, et al.
Biomedicines|November 27, 2024
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?Paschalis Karakasis, Marios Sagris, Dimitrios Patoulias, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 21, 2018
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanismsManfredi Rizzo, Dragana Nikolic, Angelo Maria Patti, et al.
Medicina (Kaunas, Lithuania)|April 26, 2025
Incretin-Based Therapies and Cancer: What's New?Sanja Medenica, Jelena Bogdanovic, Jelena Vekic, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging StrategiesSyed Arman Rabbani, Manita Saini, Mohamed El-Tanani, et al.
Current Pharmaceutical Design|March 21, 2017
Nutraceuticals as an Important Part of Combination Therapy in DyslipidaemiaAngelo M Patti, Peter P Toth, Rosaria V Giglio, et al.
Molecular Medicine Reports|August 31, 2016
Plasma heme oxygenase-1 is decreased in peripheral artery disease patientsSalvatore Santo Signorelli, Guido Li Volsi, Valerio Fiore, et al.
Metabolites|November 10, 2022
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular PreventionAmalia Despoina Koutsogianni, Petros Spyridonas Adamidis, Fotios Barkas, et al.
Pageof 53